DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,412 filers reported holding DANAHER CORPORATION in Q3 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $298,675,615 | -9.3% | 1,203,852 | -12.2% | 1.97% | +2.6% |
| Q2 2023 | $329,228,834 | +69.9% | 1,371,787 | +78.4% | 1.92% | +74.3% |
| Q1 2023 | $193,750,294 | -5.8% | 768,737 | -0.8% | 1.10% | -6.9% |
| Q4 2022 | $205,590,467 | +14.8% | 774,587 | +11.7% | 1.18% | +0.9% |
| Q3 2022 | $179,053,000 | -3.8% | 693,224 | -5.5% | 1.17% | +2.3% |
| Q2 2022 | $186,058,000 | +1.3% | 733,857 | -3.4% | 1.15% | +13.6% |
| Q1 2022 | $183,617,000 | -45.4% | 759,904 | -25.6% | 1.01% | -21.6% |
| Q4 2021 | $336,209,000 | +6.0% | 1,021,881 | -1.9% | 1.29% | +1.8% |
| Q3 2021 | $317,209,000 | +10.5% | 1,041,942 | -2.6% | 1.27% | +17.2% |
| Q2 2021 | $287,140,000 | +65.4% | 1,069,980 | +38.7% | 1.08% | +59.1% |
| Q1 2021 | $173,647,000 | +237772.6% | 771,488 | +235829.1% | 0.68% | – |
| Q4 2020 | $73,000 | +4.3% | 327 | 0.0% | 0.00% | – |
| Q3 2020 | $70,000 | +20.7% | 327 | 0.0% | 0.00% | – |
| Q2 2020 | $58,000 | +28.9% | 327 | 0.0% | 0.00% | – |
| Q1 2020 | $45,000 | -10.0% | 327 | 0.0% | 0.00% | – |
| Q4 2019 | $50,000 | +6.4% | 327 | 0.0% | 0.00% | – |
| Q3 2019 | $47,000 | 0.0% | 327 | 0.0% | 0.00% | – |
| Q2 2019 | $47,000 | +9.3% | 327 | 0.0% | 0.00% | – |
| Q1 2019 | $43,000 | -30.6% | 327 | -46.0% | 0.00% | – |
| Q4 2018 | $62,000 | -6.1% | 605 | 0.0% | 0.00% | – |
| Q3 2018 | $66,000 | +407.7% | 605 | +348.1% | 0.00% | – |
| Q2 2018 | $13,000 | 0.0% | 135 | 0.0% | 0.00% | – |
| Q1 2018 | $13,000 | – | 135 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |